216 results on '"Ritchey, Mary"'
Search Results
2. Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study
3. Intravenous Immunoglobulin Treatment Patterns and Outcomes in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims Database Analysis
4. Assessment of Codispensing Patterns of Mirabegron and Prespecified CYP2D6 Substrates in Patients with Overactive Bladder
5. CYP2D6 Substrate Dispensing Among Patients Dispensed Mirabegron: An Administrative Claims Analysis
6. Can Weight of Evidence, Quantitative Bias, and Bounding Methods Evaluate Robustness of Real-world Evidence for Regulator and Health Technology Assessment Decisions on Medical Interventions?
7. Falls and Fractures in Patients with Parkinson’s Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort Study
8. Intrauterine device-related uterine perforation incidence and risk (APEX-IUD): a large multisite cohort study
9. A systematic review and meta-analyses on the prevalence of pregnancy outcomes in migraine treated patients: a contribution from the IMI2 ConcePTION project
10. Data sources and applied methods for paclitaxel safety signal discernment
11. Demonstrating that Real World Evidence Is Fit-For-Purpose to Support Labeling: Parallels to Patient Reported Outcomes in the Pursuit of Labeling Claims
12. Economic impact analysis of the coronary heart disease-attributed health care cost savings and productivity gains from the use of Psyllium
13. Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review
14. Review of survival, safety, and clinical outcomes in HER2+ metastatic gastric cancer following the administration of trastuzumabPost-Trastuzumab Gastric Cancer
15. Evaluating the Feasibility of Electronic Health Records and Claims Data Sources for Specific Research Purposes
16. The future of clinical trials
17. Replication and reproducibility
18. Important design considerations in Pragmatic Randomized Clinical Trials
19. Special topic
20. Contributors
21. Special considerations of interventions
22. Evaluating the feasibility of data sources for pragmatic clinical trials
23. Introduction
24. Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer
25. Risks of Uterine Perforation and Expulsion Associated With Intrauterine Devices
26. Association between intrauterine device type and risk of perforation and device expulsion: results from the Association of Perforation and Expulsion of Intrauterine Device study
27. Association between menorrhagia and risk of intrauterine device–related uterine perforation and device expulsion: results from the Association of Uterine Perforation and Expulsion of Intrauterine Device study
28. Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion
29. CYP2D6 Substrate Dispensing Among Patients Dispensed Mirabegron: An Administrative Claims Analysis
30. List of Contributors
31. Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion
32. Core concepts in pharmacoepidemiology: Validation of health outcomes of interest within real‐world healthcare databases
33. No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer’s disease and related dementia: results from the Drug Repurposing for Effective Alzheimer’s Medicines study
34. Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review
35. Characterization of Sitagliptin Use in Patients with Type 2 Diabetes and Chronic Kidney Disease by Cross-Sectional Analysis of a Medical Insurance Claims Database
36. Real‐world data: Assessing electronic health records and medical claims data to support regulatory decision‐making for drug and biological products
37. Core concepts in pharmacoepidemiology: Validation of health outcomes of interest within real‐world healthcare databases.
38. Association of the Timing of Postpartum Intrauterine Device Insertion and Breastfeeding With Risks of Intrauterine Device Expulsion
39. Validity of Drug and Diagnosis Data in Pharmacoepidemiology
40. Falls and Fractures in Patients with Parkinson’s Disease-Related Psychosis Treated with Pimavanserin vs Atypical Antipsychotics: A Cohort Study
41. From Clinical Phenotype to Genotypic Modelling: Incidence and Prevalence of Recessive Dystrophic Epidermolysis Bullosa (RDEB) [Corrigendum]
42. Design of the Association of Uterine Perforation and Expulsion of Intrauterine Device study: a multisite retrospective cohort study
43. Chapter 25 - Special considerations of interventions: Medical devices
44. Chapter 1 - Introduction
45. Chapter 8 - Important design considerations in Pragmatic Randomized Clinical Trials
46. Chapter 31 - The future of clinical trials
47. Chapter 7 - Evaluating the feasibility of data sources for pragmatic clinical trials
48. Chapter 20 - Replication and reproducibility
49. Chapter 26 - Special topic: Rare disease
50. Additional file 1 of Prognostic factors of brain metastasis and survival among HER2-positive metastatic breast cancer patients: a systematic literature review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.